Bath, UK: Ti Insight (Ti): Pharmaceutical supply chain models are evolving, according to Ti’s Global Pharmaceutical Logistics Report 2023.
The TI report cites the the primacy of customised, specific treatments at a ‘Batch Size 1’ patient level as a key driver of change. The major factors affecting the global pharmaceutical logistics industry in 2023 are:
- Changes are being forced upon the sector by a better understanding of the risks associated with global supply chains which have been pushed up the corporate agenda by the Covid-19 crisis and political tensions between the West and Russia and China
- ‘Big pharma’ companies have turned their attention to newer drugs, known as ‘biologics’ or ‘biopharmaceuticals’ which, due to their sophisticated and high value nature, have the potential for much higher profit margins than OTC drugs
- The global pharmaceutical market is still dominated on a regional level by North America, thanks to a strong US market with high levels of R&D spending and production.The Ti Global Pharmaceutical Logistics Report 2023 provides:
- Global pharmaceutical logistics market sizing and analysis
- An overview of top trends in the pharmaceutical market
- Top 10 pharmaceutical company revenues 2018-2023
- Case studies of pharmaceutical companies
- An overview of pharmaceutical logistics service providers
